Rafferty Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $240K | Sell |
|
|||||
|
2025
Q3 | $231K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.13M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Sell |
|
|||||
|
2022
Q1 | $5.38M | Buy |
|
|||||
|
2021
Q4 | $5.66M | Buy |
|
|||||
|
2021
Q3 | $3.17M | Buy |
|
|||||
|
2021
Q2 | $2.77M | Buy |
|
|||||
|
2021
Q1 | $3.08M | Buy |
|
|||||
|
2020
Q4 | $999K | Sell |
|
|||||
|
2020
Q3 | $1.86M | Buy |
|
|||||
|
2020
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q1 | $316K | Sell |
|
|||||
|
2019
Q4 | $3.86M | Sell |
|
|||||
|
2019
Q3 | $6.62M | Buy |
|
|||||
|
2019
Q2 | $5.52M | Buy |
|
|||||
|
2019
Q1 | $5.88M | Buy |
|